Introduction to the BCAN seminar section

Urol Oncol. 2010 May-Jun;28(3):328. doi: 10.1016/j.urolonc.2010.03.020.

Author

Mark Schoenberg¹

Affiliation

¹ Director of Urologic Oncology, The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.

PMID: 20439031
DOI: 10.1016/j.urolonc.2010.03.020

No abstract available

Publication types

Congress
Editorial

MeSH terms

Biomarkers, Tumor / analysis
Humans
Urinary Bladder Neoplasms*

Substances

Biomarkers, Tumor